- --------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------------------
FORM 8-K
--------------------------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): JULY 8, 2005
-----------------------
MICROTEK MEDICAL HOLDINGS, INC.
-------------------------------
(Exact name of registrant as specified in its charter)
-------------------------
GEORGIA 0-24866 58-1746149
------- ------- ----------
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
13000 DEERFIELD PARKWAY, SUITE 300, ALPHARETTA, GEORGIA 30004
(Address of principal executive office) (zip code)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (678) 896-4400
--------------------------------------------
(Former name or former address, if changed since last report)
-------------------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
|_| Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
- --------------------------------------------------------------------------------
-4-
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On July 8, 2005, Microtek Medical Holdings, Inc. (the "Company") issued a
press release announcing its anticipated net revenues for the quarter ended
June 30, 2005. This press release is attached as Exhibit 99.1 to this
report and is incorporated herein by reference.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(a) Financial Statements.
N/A
(b) Pro Forma Financial Information.
N/A
(c) Exhibits.
Exhibit Number Description
99.1 Press release dated July 8, 2005, announcing the
Company's anticipated net revenues for the quarter
ended June 30, 2005
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MICROTEK MEDICAL HOLDINGS, INC.
Date: July 8, 2005 By: /s/ Dan R. Lee
-----------------------------------
Dan R. Lee, Chairman, President and
Chief Executive Officer
By: /s/ Roger G. Wilson
-----------------------------------
Roger G. Wilson, Chief Financial
Officer
3
EXHIBIT INDEX
Exhibit Number Description
99.1 Press release dated July 8, 2005, announcing the
Company's anticipated net revenues for the quarter
ended June 30, 2005
4